| Dr Lindsey Marie Webb, MD | |
|
800 Oakridge Blvd, Lumberton, NC 28358-2330 | |
| (910) 738-2454 | |
| (910) 272-7165 |
| Full Name | Dr Lindsey Marie Webb |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 11 Years |
| Location | 800 Oakridge Blvd, Lumberton, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548600323 | NPI | - | NPPES |
| PENDING | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | D83834 (Maryland) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 2018-01431 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Abington Memorial Hospital | 3274437736 | 528 |
News Archive
ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.
The final results of the RESPOND-2 trial demonstrated that combination therapy with Boceprevir yields higher sustained virologic response (SVR) rates for patients with hepatitis C virus (HCV) genotype 1 who did not respond to or relapsed after treatment with peginterferon alpha 2b and Ribavirin.
Detrusor muscle function and efficiency decline with increasing age, a urodynamic study of women with stress urinary incontinence indicates.
Producing effective epidermal electronics requires a strong, biocompatible interface between a biological surface and a sensor. Here, a KAIST team employed a calcium-modified silk fibroin as a biocompatible and strong adhesive.
› Verified 4 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821042508 PECOS PAC ID: 3274437736 Enrollment ID: O20040115000001 |
News Archive
ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.
The final results of the RESPOND-2 trial demonstrated that combination therapy with Boceprevir yields higher sustained virologic response (SVR) rates for patients with hepatitis C virus (HCV) genotype 1 who did not respond to or relapsed after treatment with peginterferon alpha 2b and Ribavirin.
Detrusor muscle function and efficiency decline with increasing age, a urodynamic study of women with stress urinary incontinence indicates.
Producing effective epidermal electronics requires a strong, biocompatible interface between a biological surface and a sensor. Here, a KAIST team employed a calcium-modified silk fibroin as a biocompatible and strong adhesive.
› Verified 4 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1316189855 PECOS PAC ID: 3274437736 Enrollment ID: O20091218000204 |
News Archive
ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.
The final results of the RESPOND-2 trial demonstrated that combination therapy with Boceprevir yields higher sustained virologic response (SVR) rates for patients with hepatitis C virus (HCV) genotype 1 who did not respond to or relapsed after treatment with peginterferon alpha 2b and Ribavirin.
Detrusor muscle function and efficiency decline with increasing age, a urodynamic study of women with stress urinary incontinence indicates.
Producing effective epidermal electronics requires a strong, biocompatible interface between a biological surface and a sensor. Here, a KAIST team employed a calcium-modified silk fibroin as a biocompatible and strong adhesive.
› Verified 4 days ago
| Entity Name | Abington Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1548825243 PECOS PAC ID: 3274437736 Enrollment ID: O20190723002404 |
News Archive
ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.
The final results of the RESPOND-2 trial demonstrated that combination therapy with Boceprevir yields higher sustained virologic response (SVR) rates for patients with hepatitis C virus (HCV) genotype 1 who did not respond to or relapsed after treatment with peginterferon alpha 2b and Ribavirin.
Detrusor muscle function and efficiency decline with increasing age, a urodynamic study of women with stress urinary incontinence indicates.
Producing effective epidermal electronics requires a strong, biocompatible interface between a biological surface and a sensor. Here, a KAIST team employed a calcium-modified silk fibroin as a biocompatible and strong adhesive.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lindsey Marie Webb, MD 2002 N Cedar St Ste B, Lumberton, NC 28358-3926 Ph: (910) 272-3048 | Dr Lindsey Marie Webb, MD 800 Oakridge Blvd, Lumberton, NC 28358-2330 Ph: (910) 738-2454 |
News Archive
ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.
The final results of the RESPOND-2 trial demonstrated that combination therapy with Boceprevir yields higher sustained virologic response (SVR) rates for patients with hepatitis C virus (HCV) genotype 1 who did not respond to or relapsed after treatment with peginterferon alpha 2b and Ribavirin.
Detrusor muscle function and efficiency decline with increasing age, a urodynamic study of women with stress urinary incontinence indicates.
Producing effective epidermal electronics requires a strong, biocompatible interface between a biological surface and a sensor. Here, a KAIST team employed a calcium-modified silk fibroin as a biocompatible and strong adhesive.
› Verified 4 days ago
Christine Marie Mellon, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 725 Oakridge Blvd, Suite C-1, Lumberton, NC 28358 Phone: 910-738-9601 Fax: 910-671-8261 | |
Dr. Larry A Hearne, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 800 Oakridge Blvd, Lumberton, NC 28358 Phone: 910-738-2454 Fax: 910-671-9303 | |
Dr. Edwin L Baker Iii, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 800 Oakridge Blvd, Lumberton, NC 28358 Phone: 910-738-2454 Fax: 910-671-9303 | |
Mr. William Troy Turlington Iv, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 800 Oakridge Blvd, Lumberton, NC 28358 Phone: 910-738-2454 Fax: 910-272-7165 | |
Walter Neal Jr., M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 725 Oakridge Blvd, Ste C-1, Lumberton, NC 28358 Phone: 910-608-3078 Fax: 910-608-3079 | |
Dr. Tawanda B Williams, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 800 Oakridge Blvd, Lumberton, NC 28358 Phone: 910-738-2454 Fax: 910-272-7165 |